SureClick® (Darbepoetin alfa) can improve perceived satisfaction and competence for anemia treatment and increase self-administration in non-dialyzed patients with chronic kidney disease Grupo del Estudio PREFERENCE, Xavier Bonafont, Ramón Romero, Romero, Isabel Martínez, Martínez, María D. del Pino, del Pino, José M. Gil, Gil, Pedro Aranda, Aranda, Ramón Roca, Claverol, Joana Claverol, Cucala, Mercedes Cucala

Importance of ultrapure dialysis liquid in response to the treatment of renal anaemia with darbepoetin in patients receiving haemodialysis M MOLINA NEFROLOGÍA HOSPITAL SANTA MARÍA ROSELL, M.J. NAVARRO NEFROLOGÍA HOSPITAL SANTA MARÍA ROSELL, M.E. PALACIOS NEFROLOGÍA NEFROCLUB CARTHAGO, M.C

Resistance index to epoetin alfa and to darbepoetin-alfa in chronic hemodialysis patients: a cohort study Rafael Perez-Garcia Nefrologia H.U. Gregorio Marañon, Patrocinio Rodríguez Benítez Nefrologia H.U. Gregorio Marañon, Rosa Jofre Nefrologia H.U. Grego